EnglishThe Skinny Jab 
Medically Supervised Weight Loss with Wegovy (Semaglutide)
At SW1 Clinic, we understand that weight loss is not simply about calorie counting. It involves a complex interplay of hormones, metabolism, genetics, and lifestyle. For patients struggling with excess weight, we offer Wegovy (semaglutide) injections as part of a clinically supervised, evidence-based medical weight management program.
Wegovy is a once-weekly, FDA-approved injectable medication for long-term weight loss in adults with obesity, or those who are overweight with related medical conditions such as hypertension, insulin resistance, or PCOS. It works by mimicking GLP-1, a gut-derived hormone that enhances satiety, reduces appetite, and slows gastric emptying — resulting in lower food intake and gradual, sustained fat loss.
Why Wegovy?
Wegovy contains a higher dose of semaglutide than Ozempic, making it more effective for weight reduction. In the pivotal STEP 1 trial, published in the New England Journal of Medicine (Wilding et al., 2021), participants receiving Wegovy lost an average of 14.9% of their body weight over 68 weeks, compared to 2.4% with placebo.
In clinical use, many patients lose 15–17% of their body weight, making it one of the most powerful non-surgical options available.
Unlike appetite suppressants or restrictive diets, Wegovy addresses the neurohormonal drivers of obesity, making it a tool for sustainable metabolic change — especially when supported by medical oversight and lifestyle coaching.
What to Expect
- Weekly subcutaneous injections, administered at home after medical clearance
- Stepwise dose titration to reduce gastrointestinal side effects
- Comprehensive doctor consultation prior to initiation
- Regular reviews to monitor progress, adjust dose, and provide accountability
Who is it for?
Wegovy is indicated for adults with:
- BMI ≥30 (obesity), or
- BMI ≥27 with at least one weight-related comorbidity
It is not meant for short-term or aesthetic weight loss. Medical evaluation is mandatory to assess suitability.
Combination Therapies for Enhanced Results
At SW1 Clinic, we combine internal metabolic solutions with external body contouring to optimise fat reduction and body definition:
Onda Body Toning (Coolwaves® Technology)
Onda uses microwave-based Coolwaves® to selectively target subcutaneous fat while also improving skin laxity and cellulite. In a 2020 clinical trial (Rossi et al., J Cosmet Dermatol), participants showed significant fat layer reductionand visible skin tightening after just 4 sessions. It is ideal for patients wanting to tone areas like the abdomen, thighs, and flanks.
CoolShape uses controlled cooling to crystallise and destroy fat cells without surgery or downtime. Based on a systematic review published in Lasers in Surgery and Medicine (2015), cryolipolysis reduces fat layer thickness by 20–25% per treatment area, with minimal side effects. It is a non-invasive option to debulk stubborn pockets of fat unresponsive to diet or exercise.
Real, Sustainable Results
The Skinny Jab is not a fad. It is a medically supervised strategy for individuals whose weight has become resistant to traditional efforts. By targeting the biological drivers of weight gain and pairing it with cutting-edge body sculpting, we help our patients achieve a healthier, more confident version of themselves — safely and sustainably.
Ready to begin?
Schedule a consultation with our medical team to find out if Wegovy is right for you.
All prescriptions at SW1 are made only after a full medical assessment.
